Sanius pivotal in NICE approval of sickle cell therapy for NHS use
Earlier today, UK-based regulator the National Institute for Health and Care Excellence (NICE) approved Voxelotor for use across the NHS to treat over 4,000 Sickle Cell Disease (SCD) patients. After years of setbacks in its approval, with support from novel data generation firm Sanius Health, the therapy will provide thousands of patients with SCD across […]